Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Cash Flow-to-Debt Ratio
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥62.99 Million could theoretically repay 0% of its total liabilities (CN¥1.02 Billion) in one year. See Tonghua Dongbao Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Tonghua Dongbao Pharmaceutical Co Ltd across 28 annual periods. Also explore Tonghua Dongbao Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Tonghua Dongbao Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600867 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.86x | CN¥689.23 Million | CN¥798.84 Million | ▲ +83.6% |
| 2024 | 0.47x | CN¥459.74 Million | CN¥978.08 Million | ▼ -69.7% |
| 2023 | 1.55x | CN¥861.52 Million | CN¥555.08 Million | ▼ -63.9% |
| 2022 | 4.30x | CN¥863.09 Million | CN¥200.74 Million | ▲ +13.6% |
| 2021 | 3.78x | CN¥1.13 Billion | CN¥299.87 Million | ▼ -22.6% |
| 2020 | 4.89x | CN¥1.19 Billion | CN¥243.80 Million | ▲ +44.8% |
| 2019 | 3.38x | CN¥1.15 Billion | CN¥341.10 Million | ▲ +180.8% |
| 2018 | 1.20x | CN¥876.94 Million | CN¥729.06 Million | ▼ -73.1% |
| 2017 | 4.46x | CN¥961.19 Million | CN¥215.30 Million | ▲ +348.9% |
| 2016 | 0.99x | CN¥725.76 Million | CN¥729.76 Million | ▲ +342.0% |
| 2015 | 0.23x | CN¥294.58 Million | CN¥1.31 Billion | ▼ -13.0% |
| 2014 | 0.26x | CN¥205.89 Million | CN¥795.72 Million | ▼ -20.6% |
| 2013 | 0.33x | CN¥221.06 Million | CN¥678.23 Million | ▼ -34.8% |
| 2012 | 0.50x | CN¥194.32 Million | CN¥388.92 Million | ▲ +371.6% |
| 2011 | -0.18x | CN¥-55.07 Million | CN¥299.37 Million | ▼ -152.0% |
| 2010 | 0.35x | CN¥160.40 Million | CN¥453.75 Million | ▲ +32.9% |
| 2009 | 0.27x | CN¥166.20 Million | CN¥624.75 Million | ▲ +112.6% |
| 2008 | 0.13x | CN¥92.31 Million | CN¥737.66 Million | ▼ -23.9% |
| 2007 | 0.16x | CN¥120.94 Million | CN¥734.97 Million | ▼ -28.0% |
| 2006 | 0.23x | CN¥158.00 Million | CN¥691.13 Million | ▲ +34.9% |
| 2005 | 0.17x | CN¥92.23 Million | CN¥544.23 Million | ▲ +518.0% |
| 2004 | 0.03x | CN¥13.17 Million | CN¥480.12 Million | ▼ -76.3% |
| 2003 | 0.12x | CN¥45.51 Million | CN¥393.95 Million | ▼ -25.8% |
| 2002 | 0.16x | CN¥31.99 Million | CN¥205.52 Million | ▼ -89.7% |
| 2001 | 1.51x | CN¥117.73 Million | CN¥77.96 Million | ▲ +128.7% |
| 2000 | 0.66x | CN¥29.12 Million | CN¥44.10 Million | ▲ +164.4% |
| 1999 | -1.02x | CN¥-95.09 Million | CN¥92.79 Million | ▼ -18.0% |
| 1998 | -0.87x | CN¥-216.98 Million | CN¥249.82 Million | — |